Table 2 Patient baseline characteristics of NPC patients after PSM
Characteristic | NTZ group N = 50 (%) | Non-NTZ group N = 50 (%) | P value |
|---|---|---|---|
Gender | 0.856 | ||
Male | 34 (68.00) | 66 (66.00) | |
Female | 16 (32.00) | 34 (34.00) | |
Age | 1.00 | ||
≤ 50 | 33 (66.00) | 66 (66.00) | |
> 50 | 17 (34.00) | 34 (34.00) | |
T classification | 0.937 | ||
T1 | 6 (12.00) | 11 (11.00) | |
T2 | 7 (14.00) | 10 (10.00.) | |
T3 | 20 (40.00) | 48 (48.00) | |
T4 | 17 (34.00) | 31 (31.00) | |
N classification | 0.925 | ||
N0 | 3 (6.00) | 9 (9.00) | |
N1 | 17 (34.00) | 28 (28.00) | |
N2 | 18 (36.00) | 42 (42.00) | |
N3 | 12 (24.00) | 21 (21.00) | |
Clinical stage | 0.565 | ||
III | 23 (46.00) | 51 (51.00) | |
IV | 27 (54.00) | 49 (49.00) | |